Keywords: Body mass index; CYP2C9; CYP4F2; Gene-environment interaction; Major bleeding; VKORC1; Warfarin;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms
Keywords: Venous thromboembolism; Vitamin K antagonists; Acenocoumarol; Warfarin; Genetic polymorphisms; AF; atrial fibrillation; APOE; apolipoprotein E; AUC; area under the curve; CI; confidence interval; CRNM bleeding; clinically relevant non-major bleeding; CYP2
Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE)
Keywords: CYP4F2; Arachidonic acid; 20-HETE; Genetic polymorphism;
CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes
Keywords: Alcohol liver disease; Ethanol; α-Tocopherol; CYP4F2; PPAR-γ; SREBP-1;
Functional characterization of a common CYP4F11 genetic variant and identification of functionally defective CYP4F11 variants in erythromycin metabolism and 20-HETE synthesis
Keywords: CYP4F2; CYP4F11; 20-Hydroxyeicosatetraenoic acid; Erythromycin; Arachidonic acid; Genetic variants; CYP; cytochrome P450; ARA; arachidonic acid; 20-HETE; 20-hydroxyeicosatetraenoic acid; PCR; polymerase chain reaction; SNP; single nucleotide polymorphism;
Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E)
Keywords: Vitamin E; Alpha-tocopherol; NAFLD; NASH; CYP4F2; PPAR-γ; SREBP;
Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis
Keywords: INR; International Normalized Ratio; CYP2C9; Cytochrome P450 Complex Subunit 2C9; CYP4F2; Cytochrome P450 Complex Subunit 4F2; VKORC1; Vitamin K Epoxide Reductase Complex Subunit 1; SNPs; Single Nucleotide Polymorphisms; MDWD; Mean Daily Warfarin Dose; CI
Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy
Keywords: Warfarin; Vitamin K1; Menaquinone-4; CYP4F2; VKORC1; CYP2C9;
Original Research ArticleIntakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism
Keywords: Population genetics; Omega-3 fatty acids; CYP4F2; Eicosanoids; EET; 20-HETE;
Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite α-(13'-hydroxy)-6-hydroxychroman
Keywords: LCM; long-chain metabolite; TOH; tocopherol; T3; tocotrienol; TQ; tocopheryl quinone; α-13â²-OH; α-13â²-(6-hydroxy-2,5,7,8,-tetramethylchroman-2-yl)-2,6,10-trimethyltridecanol; α-13â²-COOH; α-13â²-(6-hydroxy-2,5,7,8, -tetramethylchroman-2-yl)-2,6,
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses
Keywords: Warfarin; Pharmacogenetics; Polymorphism; VKORC1; CYP2C9; CYP4F2;
Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients
Keywords: Warfarin; pharmacogenetics; low intensity anticoagulation; CYP2C9; VKORC1; CYP4F2
The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes
Keywords: Cytochrome P450; 20-HETE; Genetics; Metabolic syndrome; CYP4F2; Triglycerides
Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis
Keywords: INR; International Normalized Ratio; CYP2C9; CytochromeP450 Complex Subunit2C9; VKORC1; Vitamin K Epoxide Reductase Complex Subunit 1; CYP4F2; CytochromeP450 Complex Subunit 14Â F2; CI; Confidence Interval; HLM; Human Liver Microsomes; MDWD; Mean Daily Wa
Effects of CYP4F2 Polymorphism on Response to Warfarin During Induction Phase: A Prospective, Open-Label, Observational Cohort Study
Keywords: 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors; CYP4F2; pharmacogenetics; statin; variability; warfarin
A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism
Keywords: Regression model; Pharmacogenomics; CYP2C9; VKORC1; CYP4F2
Inhibition of oxidative metabolism of tocopherols with ω-N-heterocyclic derivatives of vitamin E
Keywords: Tocopherol; Tocotrienol; Vitamin E; Oxidative metabolism; CYP4F2; CYP3A4; Enzyme inhibition
Expression of CYP4F2 in human liver and kidney: Assessment using targeted peptide antibodies
Keywords: CYP450; CYP4F2; Fatty acids; Eicosanoids; ω-Hydroxylation; Peptide antibodies
Dietary zinc restriction in rats alters antioxidant status and increases plasma F2 isoprostanes
Keywords: Zinc deficiency; Oxidative stress; Isoprostanes; Antioxidants; Vitamin E; Vitamin C; FRAP; CYP4F2; TTP
Renal and hepatic accumulation of cadmium and lead in the expression of CYP4F2 and CYP2E1
Keywords: Metal toxins; Cadmium; Lead; Zinc; Copper; Environmental exposure; CYP2E1; CYP4F2; Human liver; Human kidney;